1DanieL DV.The future of cancer research.Oncol Issues,2002,17:38-40.
2Patricia A,Fetsch MT,Nicole L,et al.Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry.Am J Clin Pathol,2002,118:870-876.
3Liotta LA,Kohn EC.The micro environment of the tumor host interface.Nature,2001,411:375-379.
4Jr GW,Cazares LH,Leung SM,et al.Proteinchip surface enhanced laser desorption ionizaton(SELDI)mass spectrometry:a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.Prostate Cancer Prostatic Dis,1999,2:264-276.
5Xiao Z,Adam BL,Cazares LH,et al.Quatitation of serum prostate specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malign antprostate disease.Cancer Res,2001,61:6029-6033.
6Adam BL,Qu Y,Davis JW,et al.Serum protein finger printing coupled with a pattern matching algorithm distinguish esprostate cancer from benign prostate hyperplasia and health men.Cancer Res,2002,62:3609-3614.
7Wellmann A,Wollscheid V,Lu H,et al.Analysis of micro dissected prostate tissue with Protein Chip arrays away to new in sights into carinogenesis and to diagnostic tools.Int J Mol Med,2002,9:341-347.
8Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359:572 -577.
9Rosty C,Christa L,Kuzal S,et al.Identification of hepatocarcinoma -intestine -pancreas/ pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.Cancer Res,2002,62:1868-1875.
10Vlahou A,Schellhammer PF,Medrinos S,et al.Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.Am J Pathol,2001,158:1491-1502.
二级参考文献9
1Smith R A, Mettlin C S, Davis K J, et al. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin, 2000, 50(1): 34 -49.
2Bichsel V E, Liotta L A, Petricoin E F, et al. Cancer proteomics: from biomarker discovery to signal pathway profiling.Cancer J, 2001, 7(1): 69 - 78.
3Eggeling F V, Junker K, Fiedler W, et al. Mass spectrometry meets chip technology: A new proteomic tool in cancer research?Electrophoresis, 2001, 22:2898 - 2902.
4Eggeling F V, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with Protein Chip array technologies:applications in cancer research. Biotechniques, 2000, 29(5): 1066 - 1070.
5Paweletz C, Trock B, Pennanen M, et al. Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Marker, 2001, 17(4): 301 - 307.
6Vlahou A, Schellhammer P F, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. American Journal of Pathology, 2001, 158(4): 1491 - 1502.
7Petricoin E F, Ardekani A M, Hitt B A, et al. Use of proteomic patterns in serum to identify ovarian cancer. The Lancet, 2002,359:572 - 577.
